Search research articles
Contact Us
Filters
Showing results (301-310 of 349) with videos related to
Page
of 35
Sort By:
Zhonghua Nei Ke Za Zhi
|
September 5, 2012
[The efficacy and safety of continuous erythropoietin receptor activator in dialytic patients with chronic renal anemia: an open, randomized, controlled, multi-center trial]
Nan Chen, Jia-qi Qian, Chang-lin Mei, et al.
Kidney International
|
April 20, 2021
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
David C Wheeler, Robert D Toto, Bergur V Stefánsson, et al.
European Journal of Preventive Cardiology
|
August 1, 2015
Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers
Bauke Schievink, Dick de Zeeuw, Paul A Smink, et al.
Journal of the American Heart Association
|
March 15, 2017
China Stroke Primary Prevention Trial: Visit-to-Visit Systolic Blood Pressure Variability Is an Independent Predictor of Primary Stroke in Hypertensive Patients
Xi Men, Wei Sun, Fangfang Fan, et al.
Chinese Medical Journal
|
October 10, 2012
Current pattern of Chinese dialysis units: a cohort study in a representative sample of units
Qiu-Gen Zhou, Jian-Ping Jiang, Sheng-Jie Wu, et al.
Theranostics
|
February 23, 2024
MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity
Shan Zhou, Xian Ling, Jielin Zhu, et al.
Pharmacological Research
|
August 29, 2024
Omega-3 PUFAs slow organ aging through promoting energy metabolism
Yabing Xiong, Xiaolong Li, Jiafeng Liu, et al.
Stroke
|
December 24, 2017
Effect of Smoking and Folate Levels on the Efficacy of Folic Acid Therapy in Prevention of Stroke in Hypertensive Men
Ziyi Zhou, Jianping Li, Yaren Yu, et al.
Circulation
|
November 13, 2020
Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease
John J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.
Nature Medicine
|
August 20, 2020
Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
Xin Xu, Jian Sun, Sheng Nie, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 349) with videos related to
Sort By:
Page
of 35
Zhonghua Nei Ke Za Zhi
|
September 5, 2012
[The efficacy and safety of continuous erythropoietin receptor activator in dialytic patients with chronic renal anemia: an open, randomized, controlled, multi-center trial]
Nan Chen, Jia-qi Qian, Chang-lin Mei, et al.
Kidney International
|
April 20, 2021
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
David C Wheeler, Robert D Toto, Bergur V Stefánsson, et al.
European Journal of Preventive Cardiology
|
August 1, 2015
Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers
Bauke Schievink, Dick de Zeeuw, Paul A Smink, et al.
Journal of the American Heart Association
|
March 15, 2017
China Stroke Primary Prevention Trial: Visit-to-Visit Systolic Blood Pressure Variability Is an Independent Predictor of Primary Stroke in Hypertensive Patients
Xi Men, Wei Sun, Fangfang Fan, et al.
Chinese Medical Journal
|
October 10, 2012
Current pattern of Chinese dialysis units: a cohort study in a representative sample of units
Qiu-Gen Zhou, Jian-Ping Jiang, Sheng-Jie Wu, et al.
Theranostics
|
February 23, 2024
MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity
Shan Zhou, Xian Ling, Jielin Zhu, et al.
Pharmacological Research
|
August 29, 2024
Omega-3 PUFAs slow organ aging through promoting energy metabolism
Yabing Xiong, Xiaolong Li, Jiafeng Liu, et al.
Stroke
|
December 24, 2017
Effect of Smoking and Folate Levels on the Efficacy of Folic Acid Therapy in Prevention of Stroke in Hypertensive Men
Ziyi Zhou, Jianping Li, Yaren Yu, et al.
Circulation
|
November 13, 2020
Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease
John J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.
Nature Medicine
|
August 20, 2020
Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
Xin Xu, Jian Sun, Sheng Nie, et al.
Page
of 35